News

Higher Distress Scores Linked With Lower Survival in Myeloma

With several new agents entering the treatment landscape, patients with multiple myeloma are facing different toxicity, financial, and psychological burdens. As a chronic disease, additional attention is needed to address these issues and improve patients’ overall quality of life, according to John Richter, M.D.

Read full article on onclive.com.